51. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation
- Author
-
Pascale Frere, Vincent Bours, Georges Fillet, Yves Beguin, Emilie Castermans, Etienne Baudoux, Nathalie Meuris, Nicole Schaaf-Lafontaine, Stephanie Humblet-Baron, and Frédéric Baron
- Subjects
Adult ,CD4-Positive T-Lymphocytes ,Male ,medicine.medical_specialty ,Time Factors ,Cyclophosphamide ,T-Lymphocytes ,Antigens, CD34 ,Biology ,CD8-Positive T-Lymphocytes ,Gastroenterology ,Donor lymphocyte infusion ,Lymphocyte Depletion ,Antigens, CD ,Internal medicine ,Neoplasms ,medicine ,Humans ,Lymphocyte Count ,Aged ,Transplantation ,Myelodysplastic syndromes ,Histocompatibility Testing ,Middle Aged ,medicine.disease ,Fludarabine ,Killer Cells, Natural ,Leukemia ,Haematopoiesis ,Treatment Outcome ,Myelodysplastic Syndromes ,Immunology ,Female ,CD8 ,medicine.drug ,Follow-Up Studies ,Stem Cell Transplantation - Abstract
We have previously shown that CD8 depletion or CD34 selection of peripheral blood stem cells (PBSC) reduced the incidence of acute graft-versus-host disease (GvHD) after nonmyeloablative stem-cell transplantation (NMSCT). In this study, we analyze the effect of CD8 depletion or CD34 selection of the graft on early T-cell reconstitution.Nonmyeloablative conditioning regimen consisted in 2 Gy total-body irradiation (TBI) alone, 2 Gy TBI and fludarabine, or cyclophosphamide and fludarabine. Patients 1 to 18 received unmanipulated PBSC, patients 19 to 29 CD8-depleted PBSC, and patients 30 to 35 CD34-selected PBSC.T-cell counts, and particularly CD4+ and CD4CD45RA+ counts, remained low the first 6 months after nonmyeloablative stem-cell transplantation (NMSCT) in all patients. CD34 selection (P0.0001) but not CD8 depletion of PBSC significantly decreased T-cell chimerism. Donor T-cell count was similar in unmanipulated compared with CD8-depleted PBSC recipients but was significantly lower in CD34-selected PBSC recipients (P=0.0012). T cells of recipient origin remained stable over time in unmanipulated and CD8-depleted PBSC patients but expanded in some CD34-selected PBSC recipients between day 28 and 100 after transplant. Moreover, whereas CD8 depletion only decreased CD8+ counts (P0.047), CD34 selection reduced CD3+(P0.001), CD8+(P0.016), CD4+ (P0.001), and CD4+CD45RA+ (P0.001) cell counts. T-cell repertoire was restricted in all patients on day 100 after hematopoietic stem-cell transplantation but was even more limited after CD34 selection (P=0.002).Despite of the persistence of a significant number of T cells of recipient origin, T-cell counts were low the first 6 months after NMSCT. Moreover, contrary with CD8 depletion of the graft that only affects CD8+ lymphocyte counts, CD34 selection dramatically decreased both CD8 and CD4 counts.
- Published
- 2003